|
1
|
Falk RJ and Jennette JC: ANCA small-vessel
vasculitis. J Am Soc Nephrol. 8:314–322. 1997.PubMed/NCBI
|
|
2
|
Fries JF, Hunder GG, Bloch DA, Michel BA,
Arend WP, Calabrese LH, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW
Jr, et al: The American college of rheumatology 1990 criteria for
the classification of vasculitis. Summary. Arthritis Rheum.
33:1135–1136. 1990.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jennette JC, Falk RJ, Bacon PA, Basu N,
Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen
EC, et al: 2012 revised international chapel hill consensus
conference nomenclature of vasculitides. Arthritis Rheum. 65:1–11.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lyons PA, Rayner TF, Trivedi S, Holle JU,
Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry
AN, et al: Genetically distinct subsets within ANCA-associated
vasculitis. N Engl J Med. 367:214–223. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hilhorst M, van Paassen P and Tervaert JW:
Limburg Renal Registry. Proteinase 3-ANCA vasculitis versus
myeloperoxidase-ANCA vasculitis. J Am Soc Nephrol. 26:2314–2327.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fussner LA, Hummel AM, Schroeder DR, Silva
F, Cartin-Ceba R, Snyder MR, Hoffman GS, Kallenberg CG, Langford
CA, Merkel PA, et al: Factors determining the clinical utility of
serial measurements of antineutrophil cytoplasmic antibodies
targeting proteinase 3. Arthritis Rheumatol. 68:1700–1710.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Deshayes S, Martin Silva N, Khoy K,
Yameogo S, Mariotte D, Lobbedez T and Aouba A: Clinical impact of
subgrouping ANCA-associated vasculitis according to antibody
specificity beyond the clinicopathological classification.
Rheumatology (Oxford). 58:1731–1739. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hong Y, Shi P, Liu X, Yang L, Li K, Xu F,
Liang S, Liu Z, Zhang H, Chen Y and Hu W: Distinction between
MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese
patients: A retrospective single-center study. Clin Rheumatol.
38:1665–1673. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mukhtyar C, Lee R, Brown D, Carruthers D,
Dasgupta B, Dubey S, Flossmann O, Hall C, Hollywood J, Jayne D, et
al: Modification and validation of the birmingham vasculitis
activity score (version 3). Ann Rheum Dis. 68:1827–1832.
2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen M, Xing GQ, Yu F, Liu G and Zhao MH:
Complement deposition in renal histopathology of patients with
ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial
Transplant. 24:1247–1252. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Berden AE, Ferrario F, Hagen EC, Jayne DR,
Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, et
al: Histopathologic classification of ANCA-associated
glomerulonephritis. J Am Soc Nephrol. 21:1628–1636. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen YX, Xu J, Pan XX, Shen PY, Li X, Ren
H, Chen XN, Ni LY, Zhang W and Chen N: Histopathological
classification and renal outcome in patients with antineutrophil
cytoplasmic antibodies-associated renal vasculitis: A study of 186
patients and metaanalysis. J Rheumatol. 44:304–313. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yates M, Watts RA, Bajema IM, Cid MC,
Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA,
et al: EULAR/ERA-EDTA recommendations for the management of
ANCA-associated vasculitis. Ann Rheum Dis. 75:1583–1594.
2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Huang L, Zhong Y, Ooi JD, Zhou YO, Zuo X,
Luo H, Chen JB, Wu T, Yang Y, Meng T, et al: The effect of pulse
methylprednisolone induction therapy in Chinese patients with
dialysis-dependent MPO-ANCA associated vasculitis. Int
Immunopharmacol. 76(105883)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Watts RA, Mooney J, Skinner J, Scott DG
and Macgregor AJ: The contrasting epidemiology of granulomatosis
with polyangiitis (Wegener's) and microscopic polyangiitis.
Rheumatology (Oxford). 51:926–931. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Furuta S, Chaudhry AN, Hamano Y, Fujimoto
S, Nagafuchi H, Makino H, Matsuo S, Ozaki S, Endo T, Muso E, et al:
Comparison of phenotype and outcome in microscopic polyangiitis
between Europe and Japan. J Rheumatol. 41:325–333. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Furuta S, Chaudhry AN, Arimura Y, Dobashi
H, Fujimoto S, Homma S, Rasmussen N and Jayne DR: Comparison of the
phenotype and outcome of granulomatosis with polyangiitis between
UK and Japanese cohorts. J Rheumatol. 44:216–222. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Watts RA, Lane SE, Scott DG, Koldingsnes
W, Nossent H, Gonzalez-Gay MA, Garcia-Porrua C and Bentham GA:
Epidemiology of vasculitis in Europe. Ann Rheum Dis. 60:1156–1157.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu LJ, Chen M, Yu F, Zhao MH and Wang HY:
Evaluation of a new algorithm in classification of systemic
vasculitis. Rheumatology (Oxford). 47:708–712. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wu T, Peng J, Meng T, Liu Q, Ao X, Lin W,
Yin H, Chen J, Pu J, Peng Z, et al: Clinicopathological features
and prognostic analysis of 49 cases with crescentic
glomerulonephritis. Exp Ther Med. 18:3984–3990. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Scott J, Hartnett J, Mockler D and Little
MA: Environmental risk factors associated with ANCA associated
vasculitis: A systematic mapping review. Autoimmun Rev.
19(102660)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chang DY, Li ZY, Chen M and Zhao MH:
Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a
distinct subset of ANCA-associated vasculitis: A retrospective
analysis of 455 patients from a single center in China. Semin
Arthritis Rheum. 48:701–706. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Pearce FA, Craven A, Merkel PA, Luqmani RA
and Watts RA: Global ethnic and geographic differences in the
clinical presentations of anti-neutrophil cytoplasm
antibody-associated vasculitis. Rheumatology (Oxford).
56:1962–1969. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ponte C, Agueda AF and Luqmani RA:
Clinical features and structured clinical evaluation of vasculitis.
Best Pract Res Clin Rheumatol. 32:31–51. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Franssen C, Gans R, Kallenberg C,
Hageluken C and Hoorntje S: Disease spectrum of patients with
antineutrophil cytoplasmic autoantibodies of defined specificity:
Distinct differences between patients with anti-proteinase 3 and
anti-myeloperoxidase autoantibodies. J Intern Med. 244:209–216.
1998.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Falk RJ, Hogan S, Carey TS and Jennette
JC: Clinical course of anti-neutrophil cytoplasmic
autoantibody-associated glomerulonephritis and systemic vasculitis.
The glomerular disease collaborative network. Ann Intern Med.
113:656–663. 1990.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Homma S, Suzuki A and Sato K: Pulmonary
involvement in ANCA-associated vasculitis from the view of the
pulmonologist. Clin Exp Nephrol. 17:667–671. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Franssen CF, Gans RO, Arends B, Hageluken
C, ter Wee PM, Gerlag PG and Hoorntje SJ: Differences between
anti-myeloperoxidase- and anti-proteinase 3-associated renal
disease. Kidney Int. 47:193–199. 1995.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kemna MJ, Damoiseaux J, Austen J, Winkens
B, Peters J, van Paassen P and Cohen Tervaert JW: ANCA as a
predictor of relapse: Useful in patients with renal involvement but
not in patients with nonrenal disease. J Am Soc Nephrol.
26:537–542. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sinico RA, Radice A, Corace C, DI Toma L
and Sabadini E: Value of a new automated fluorescence immunoassay
(EliA) for PR3 and MPO-ANCA in monitoring disease activity in
ANCA-associated systemic vasculitis. Ann N Y Acad Sci.
1050:185–192. 2005.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu Y, Zhang Y, Liu D, Tan X, Tang X,
Zhang F, Xia M, Chen G, He L, Zhou L, et al: Prediction of ESRD in
IgA nephropathy patients from an Asian cohort: A random forest
model. Kidney Blood Press Res. 43:1852–1864. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li D, Zou L, Feng Y, Xu G, Gong Y, Zhao G,
Ouyang W, Thurman JM and Chao W: Complement factor B production in
renal tubular cells and its role in sodium transporter expression
during polymicrobial sepsis. Crit Care Med. 44:e289–e299.
2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Xiao H, Schreiber A, Heeringa P, Falk RJ
and Jennette JC: Alternative complement pathway in the pathogenesis
of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Am J Pathol. 170:52–64. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fukui S, Iwamoto N, Takatani A, Igawa T,
Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Tamai M, et
al: Antineutrophilic cytoplasmic antibody-associated vasculitis
with and without renal involvement: C3 contributes to prognosis,
but renal involvement does not. Int J Rheum Dis. 22:789–796.
2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Choi H, Kim Y, Jung SM, Song JJ, Park YB
and Lee SW: Low serum complement 3 level is associated with severe
ANCA-associated vasculitis at diagnosis. Clin Exp Nephrol.
23:223–230. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu H, Peng Y, Liu H, Liu Y, Yuan S, Liu
F, Yang D, Chen X, He L, Fu M, et al: Renal biopsy findings of
patients presenting with isolated hematuria: Disease associations.
Am J Nephrol. 36:377–385. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hauer HA, Bajema IM, van Houwelingen HC,
Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA
and Hagen EC: European Vasculitis Study Group (EUVAS). Renal
histology in ANCA-associated vasculitis: Differences between
diagnostic and serologic subgroups. Kidney Int. 61:80–89.
2002.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cordova-Sanchez BM, Mejía-Vilet JM,
Morales-Buenrostro LE, Loyola-Rodríguez G, Uribe-Uribe NO and
Correa-Rotter R: Clinical presentation and outcome prediction of
clinical, serological, and histopathological classification schemes
in ANCA-associated vasculitis with renal involvement. Clin
Rheumatol. 35:1805–1816. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Rihova Z, Jancova E, Merta M, Rysava R,
Reiterova J, Zabka J and Tesar V: Long-term outcome of patients
with antineutrophil cytoplasmic autoantibody-associated vasculitis
with renal involvement. Kidney Blood Press Res. 28:144–152.
2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Mohammad AJ and Segelmark M: A
population-based study showing better renal prognosis for
proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated
nephritis versus myeloperoxidase ANCA-associated nephritis. J
Rheumatol. 41:1366–1373. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
de Joode AA, Sanders JS and Stegeman CA:
Renal survival in proteinase 3 and myeloperoxidase ANCA-associated
systemic vasculitis. Clin J Am Soc Nephrol. 8:1709–1717.
2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ma Y, Han F, Chen L, Wang H, Han H, Yu B,
Xu Y and Chen J: The impact of intravenous methylprednisolone
pulses on renal survival in anti-neutrophil cytoplasmic antibody
associated vasculitis with severe renal injury patients: A
retrospective study. BMC Nephrol. 18(381)2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hauer HA, Bajema IM, Van Houwelingen HC,
Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA
and Hagen EC: European Vasculitis Study Group (EUVAS). Determinants
of outcome in ANCA-associated glomerulonephritis: A prospective
clinico-histopathological analysis of 96 patients. Kidney Int.
62:1732–1742. 2002.PubMed/NCBI View Article : Google Scholar
|
